BSEM
BioStem Technologies, Inc.Company Information
- Company Name
- BioStem Technologies, Inc.
- CIK
- CIK0001658678
- Category
- <br>Emerging growth company
- Ticker: Exchange
- BSEM: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- BSEM
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-08-12
- Price on filing date
- —
- 1-month reaction
- -2.37%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|
Assets Current | |||||||
| Cash And Cash Equivalents At Carrying Value | 7 | ||||||
| Accounts Receivable Net Current | 7 | ||||||
| Inventory Net | 5 | ||||||
| Prepaid Expense And Other Assets Current | 2 | ||||||
| Assets Current | 21 | ||||||
Assets Noncurrent | |||||||
| Property Plant And Equipment Net | 4 | ||||||
| Inventory Real Estate Construction In Process | 1 | ||||||
| Operating Lease Right Of Use Asset | 0 | ||||||
| Finite Lived Intangible Assets Net | 21 | ||||||
| Goodwill | 2 | ||||||
| Assets | 49 | ||||||
Liabilities Current | |||||||
| Accounts Payable And Accrued Liabilities Current | 9 | ||||||
| Taxes Payable Current | 0 | ||||||
| Deposit Liabilities Accrued Interest | 0 | ||||||
| Operating Lease Liability Current | 0 | ||||||
| Notes Payable Current | 1 | ||||||
| Asset Acquisition Contingent Consideration Liability Current | 10 | ||||||
| Other Liabilities Current | 0 | ||||||
| Liabilities Current | 21 | ||||||
Liabilities Noncurrent | |||||||
| Operating Lease Liability Noncurrent | 0 | ||||||
| Liabilities Noncurrent | 0 | ||||||
| Liabilities | 21 | ||||||
Temporary Equity | |||||||
| Common Stock Value | 0 | ||||||
| Additional Paid In Capital | 67 | ||||||
| Treasury Stock Value | -0 | ||||||
| Retained Earnings Accumulated Deficit | -39 | ||||||
| Stockholders Equity | 28 | ||||||
| Liabilities And Stockholders Equity | 49 | ||||||
| Series A One Convertible Preferred Shares | 0 | ||||||
| Series B One Convertible Preferred Shares | 0 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 9 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | ||||||
| Common Stock Shares Authorized | 975 | ||||||
| Common Stock Shares Issued | 18 | ||||||
| Shares Outstanding | 18 | ||||||
| Treasury Stock Common Shares | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialBioStem Technologies, Inc. (BSEM) — SEC Financial Statements & Analysis
BioStem Technologies, Inc. (BSEM) is a biological products, (no diagnostic substances) company, incorporated in FL. BioStem Technologies, Inc. trades on Nasdaq as: BSEM. BioStem Technologies, Inc. (BSEM)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, BioStem Technologies, Inc. carries a market cap of $57.18M, a P/B ratio of 2.07x, and an enterprise value of $51.22M. On the balance sheet, it maintains a current ratio of 0.98x, a quick ratio of 0.64x, working capital of $-421.29K, a debt-to-equity ratio of 0.77x, a debt ratio of 0.43, and net debt of $-5.96M. Figures sourced from SEC EDGAR.
- Market Cap
- $57.18M
- P/B TTM
- 2.07x
- Debt To Equity
- 0.77x
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is BioStem Technologies, Inc. in?
BioStem Technologies, Inc. (BSEM) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does BSEM trade on?
BioStem Technologies, Inc. (BSEM) trades on the Nasdaq.
Where is BioStem Technologies, Inc. incorporated?
BioStem Technologies, Inc. is incorporated in FL.
When was BioStem Technologies, Inc. (BSEM)'s most recent SEC filing?
BioStem Technologies, Inc. (BSEM)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.
What is BSEM's market cap?
BioStem Technologies, Inc. (BSEM) has a market capitalization of $57.18M as of 2026-06-30.